Novo Nordisk on Monday reported the oral version of its drug semaglutide reduced the risk of major adverse cardiovascular events in adults with type 2 diabetes by 14% in a large Phase III trial.

In just a few years, brand-name injectable drugs such as Ozempic, Wegovy, Mounjaro and Zepbound have rocketed to fame as ...

As Novo Nordisk’s injectable diabetes-obesity duo Ozempic and Wegovy grab all the limelight, an oral version of the ...

The Wegovy makers’s once-daily pill to treat type 2 diabetes has shown it cuts the risk of heart attacks and strokes in ...

Catalent, a leading contract drug manufacturer, issued an open letter Monday to reassure customers that a proposed $16.5 ...

The Wegovy makers’s once-daily pill to treat type 2 diabetes has shown it cuts the risk of heart attacks and strokes in ...

Here's all you need to know about Ozempic that Karan Johar is said to have used for fast weight loss. What are the benefits ...

Depending on when you last got vaccinated, that COVID-19 shot may no longer be a good match for the variants expected to ...

Labour's plan to inject people with drugs to help them lose weight and get unemployed people back to work won’t fix our ...

A new meta-analysis confirms that semaglutide drugs like Ozempic are not only effective for weight loss, but can also protect ...

What this means is that by changing only one hormone, “suddenly you change your entire relationship with food”, says Prof ...

Ruined credit scores and big risks for bankruptcy: All part of the long-term financial fallout from the words "You have ...